CFO transition
Celestica Inc. CFO transition: Todd Ankenmann to succeed Mandeep Chawla
Celestica Inc. reported in a Form 8-K filed September 11, 2026 that Todd Ankenmann will succeed Mandeep Chawla as Chief Financial Officer, effective October 1, 2026.
In the filing's words
Mandeep Chawla, the Company’s current Chief Financial Officer, will be appointed to the newly created role of Group President, Global Markets and Todd Ankenmann will be appointed Chief Financial Officer, each effective as of October 1, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Celestica Inc. (CLS) |
|---|---|
| Event | Transition |
| Incoming | Todd Ankenmann |
| Outgoing | Mandeep Chawla |
| Title in the filing | Chief Financial Officer |
| Effective | October 1, 2026 |
| 8-K filed | September 11, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Senior Vice President, Finance, Celestica Inc. |
| SEC CIK | 0001030894 |
Celestica Inc. reported this change in a Form 8-K, Item 5.02, filed September 11, 2026. The filing's own words are quoted above.
Other records naming Mandeep Chawla
1The outgoing officer on this record, matched by name. Career line.
2026-02-27 · 10-K signature
Mandeep Chawla signed Celestica Inc.'s annual report as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Todd Ankenmann? Send a correction with the primary source.